Navigation Links
Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
Date:9/10/2009

s and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvente
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
4. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
6. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
7. Medarex to Receive Milestone Payment from Amgen
8. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
9. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
10. Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
11. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... FRANCISCO, Calif. , Sept. 2, 2014   Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... Morgan Stanley Global Healthcare Unplugged Conference 2014 on Monday, September ... York . The live audio webcast and ... http://investor.veracyte.com . Please connect to the website at least ...
(Date:9/2/2014)... , Switzerland , September 2, ... ISO 13485 accreditation, Sophia Genetics has become the first ... use of a Next Generation Sequencing (NGS) bioinformatic ... represents an important step in raising the standards ... brings Sophia Genetics, world-leading Data Driven Medicine platform ...
(Date:9/2/2014)... , Sept. 2, 2014  For over a decade SafeMinds ... link between vaccines and autism. But at least for one ... In a statement , William Thompson , Ph.D. ... linking the MMR vaccine to an increased risk of autism ... the same data suggests that African American males have a ...
Breaking Medicine Technology:Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2CDC vaccine scientist admits wrongdoing. 2CDC vaccine scientist admits wrongdoing. 3
... ... that a new market research report is available in ... A Worldwide Market Review , http://www.reportlinker.com/p0164283/Decubitus-Ulcer-Treatment-Products---A-Worldwide-Market-Review.html ... damage caused by constant pressure of the patient,s bodyweight. ...
... , KING OF PRUSSIA, Pa., Nov. 30 ... Phase I study of CPSI-2364, its orally active, small-molecule inhibitor ... Results of the safety and tolerability dose escalation study in ... clinical testing. , All 30 enrolled subjects completed ...
Cached Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2
(Date:9/2/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief executive officer ... Sioux Falls, S.D. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... and nationally recognized leader in patient-centered care. It is ...
(Date:9/2/2014)... Niagara Falls, New York (PRWEB) September 02, 2014 ... scabies ?” This is the question that millions of ... challenge among health care providers, patients and their families ... lead to misdiagnosis due to its distinct similarities to ... atopic dermatitis, impetigo, bed bug bites, eczema, varicella and ...
(Date:9/2/2014)... September 02, 2014 QueenBeeTickets.com , home ... is now stocking James Taylor concert tickets for the singer’s ... U.S. cities from November 1 to the 19th. , James ... again on the 4th of the month. General onsales to ... are all set to obtain seats for one of his ...
(Date:9/2/2014)... September 02, 2014 ZAMST, a leader ... endorsement deal with professional baseball star Nolan Arenado ... best young baseball players, Arenado will be working with ... specific product category. , Arenado was selected by ... #59 overall. In 2013, Arenado was awarded the Gold ...
(Date:9/2/2014)... At the 50th Annual Mr. Olympia Fitness ... exhibitor at the Las Vegas Convention Center South Hall, ... Booth #374 Sept 19th and 20th 10am-5PM. , ... exercise, diet and supplementation. They pride themselves on creating ... for all Prosupps customers to reach their personal health ...
Breaking Medicine News(10 mins):Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:Prosupps, One of the Fastest Growing Supplement Companies, Celebrates a Success Milestone with Exhibiting at the 50th Annual 2014 Mr. Olympia’s Fitness & Performance Expo 2
... Journal has just come out. In it,s 23rd year it helps new ... progress. It is both a keepsake, and a lifesaver in an emergency. ... inception. A diaper bag must. , ... Fountain Valley, CA (PRWEB) January ...
... Robert L. Peck discusses connections between the mind and body, hormone ... aware of the effects of hormones and how many of the ... ... Lebanon, CT (PRWEB) January 21, 2009 -- ,Controlling Your Hormones, ...
... CINCINNATI After identifying an apparent population of cancer ... herpes virus to block tumor formation in mice by ... 21 by PLoS (Public Library of Science) One ... Center adds to a growing body of evidence suggesting ...
... came into effect, granting children 12 years and older ... the right to access condoms. But current policies ... give out condomspolicies that two researchers, writing in this ... health of the country,s youth. , Juliana Han (Harvard ...
... , ... (PRWEB) January 20, 2009 -- It has come ... confusion as to the intentions of its iPhone application previously for ... to its attention-grabbing name, and the unfortunate media confusion and common ...
... health and exercise programs have positive outcomes despite having ... exercise they do outside of school, say Cochrane Researchers ... physical activity programs in schools. , The research shows ... and reduced the time spent watching television. Programs also ...
Cached Medicine News:Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 2Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 3Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 2Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 3Health News:Engineered virus targets and kills apparent cancer stem cells in neuroblastoma 2Health News:Engineered virus targets and kills apparent cancer stem cells in neuroblastoma 3Health News:South African policy on adolescents' rights to access condoms is causing confusion 2Health News:Teen Torture iPhone App Discontinued Due to Public Alarm 2Health News:Teen Torture iPhone App Discontinued Due to Public Alarm 3Health News:School-based physical activity: Has benefits even if it doesn't help lose weight 2
Enzyme Immunoassay of von Willebrand Factor Antigenby ELISA Method, 96 tests....
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of Platelet Factor 4 Antigen by ELISA Method, 96 tests....
HbA1c / HbCalibrator...
Medicine Products: